The National Human Monitoring Program (NHMP) identifies concentrations of specific chemicals in human tissues, including toxicologic testing and risk assessment determinations. This volume evaluates the current activities of the NHMP; identifies important scientific, technical, and programmatic issues; and makes recommendations regarding the design of the program and use of its products.

There is a great dispar.ity between the ability of the major industrial nations to produce and distribute chemicals and our ability to comprehend the nature and potential severity of unintended consequences for man, his life support systems and the environment generally. Furthermore, the gap between our ability to produce and distribute myriad chemicals and our ability to identify, understand or predict unfavorable environmental impacts may widen. As environmental scientists we are conscious of the interrelatedness, not only of environmental systems, but of nations as well. Materials are continually moved across boundaries by human as well as natural agencies. The extent, rate and nature of transfer for most pollutants is largely unknown. We can only guess which of the numerous chemicals produced are candidates for concern. More important still is our practical ignorance of the mechanisms of chronic effects upon natural systems and of the concentrations, combinations and circumstances that may lead to irreversibilities or to serious consequences for man. We know very little also regarding the potential for or the kinds of indirect effects that might occur. With respect to the environmentltself, we know little of its assimilative capacity with regard to widely dispersed pollutants and their transformation products. But what we do know is disquieting, and a much-improved system for the evaluation and management of toxic and hazardous chemicals is needed.

Ever since the industrial revolution, large numbers of environmentally hazardous materials are in troduced into the global environment annually; a list of all substances which are at present re garded as environmentally hazardous might contain thousands of compounds, and new substan ces are still being added. Several major activities are necessary of adequately ensure the protec tion of human health and the environment from the often subtle effects of these materials. These activities include toxicological and ecological research, control technology development, the pro mulgation of regulatory guidelines and standards, and the monitoring of environmental materials and specimen banking. In the absence of effective monitoring environmental materials and spe cimen banking, the detection of serious environmental contamination from pollutants may occur only after critical damage has been done. Environmental problems are independent of national boundaries and international collaborative programmes should be encouraged. Sponsoring organisations and other international and national bodies should encourage monitoring and specimen bank programmes and develop harmonised sy stems for data acquisition and evaluation. An international pilot programme of monitoring and specimen banking is needed and is technically feasible. The conclusions and recommendations, for both implementation and research, should be of inte rest to other international and national bodies in addition to the three organisation sponsoring this International Workshop. Nevertheless this joint sponsorship should help to assure that the re sulting conclusions and recommendations will have a worldwide audience and that effective coor dination of existing programmes will be possible.

Recent years have seen a growing tendency for social scientists to collect biological specimens such as blood, urine, and saliva as part of large-scale household surveys. By combining biological and social data, scientists are opening up new fields of inquiry and are able for the first time to address many new questions and connections. But including biospecimens in social surveys also adds a great deal of complexity and cost to the investigator's task. Along with the usual concerns about informed consent, privacy issues, and the best ways to collect, store, and share data, researchers now face a variety of issues that are much less familiar or that appear in a new light. In particular, collecting and storing human biological materials for use in social science research raises additional legal, ethical, and social issues, as well as practical issues related to the storage, retrieval, and sharing of data. For example, acquiring biological data and linking them to social science databases requires a more complex informed consent process, the development of a biorepository, the establishment of data sharing policies, and the creation of a process for deciding how the data are going to be shared and used for secondary analysis-all of which add cost to a survey and require additional time and attention from the investigators. These issues also are likely to be unfamiliar to social scientists who have not worked with biological specimens in the past. Adding to the attraction of collecting biospecimens but also to the complexity of sharing and protecting the data is the fact that this is an era of incredibly rapid gains in our understanding of complex biological and physiological phenomena. Thus the tradeoffs between the risks and opportunities of expanding access to research data are constantly changing. Conducting Biosocial Surveys offers findings and recommendations concerning the best approaches to the collection, storage, use, and sharing of biospecimens gathered in social science surveys and the digital representations of biological data derived therefrom. It is aimed at researchers interested in carrying out such surveys, their institutions, and their funding agencies.

Biomonitoring—a method for measuring amounts of toxic chemicals in human tissues—is a valuable tool for studying potentially harmful environmental chemicals. Biomonitoring data have been used to confirm exposures to chemicals and validate public health policies. For example, population biomonitoring data showing high blood lead concentrations resulted in the U.S. Environmental Protection Agency's (EPA's) regulatory reduction of lead in gasoline; biomonitoring data confirmed a resultant drop in blood lead concentrations. Despite recent advances, the science needed to understand the implications of the biomonitoring data for human health is still in its nascent stages. Use of the data also raises communication and ethical challenges. In response to a congressional request, EPA asked the National Research Council to address those challenges in an independent study. Human Biomonitoring for Environmental Chemicals provides a framework for improving the use of biomonitoring data including developing and using biomarkers (measures of exposure), research to improve the interpretation of data, ways to communicate findings to the public, and a review of ethical issues.

Case studies of twelve existing human biospecimen repositories performed to evaluate their utility for genomics- and proteomics-based cancer research and to identify "best practices" in collection, processing, annotation, storage, privacy, ethical concerns, informed consent, business plans, operations, intellectual property rights, public relations, marketing, and education that would be useful in designing a national biospecimen network.

This book describes the principles and the application of the existing molecular methodology for the detection of early cancer. Discussion focuses on the molecular changes characterizing preneoplastic lesions; molecular targets for early detection; validation of molecular targets; and new diagnostic technology for early detection. The advantages of molecular detection over current methods are examined, as well as the importance of identifying and characterizing preneoplastic lesions. In addition to the uses of highly specific molecular probes to detect early cancer, this book demonstrates the many ways in which molecular markers serve oncology. While meeting pressing needs in the practice of medicine, molecular detection of early cancer scientifically necessitates a confrontation with the biology of cancer, such as the genetic determinants of progression, regression, dormancy, and invasion. This work not only discusses the diagnostic value of these molecular methods but views their practical benefits against a background of conventional morphology.